Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2026-02-13 @ 4:35 PM
Study NCT ID:
NCT02545595
Status:
COMPLETED
Last Update Posted:
2016-10-12
First Post:
2013-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients
Sponsor:
Poitiers University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2013-03-27
First Submit QC Date:
None
Study First Post Date:
2015-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-10
Last Update Post Date:
2016-10-12
Last Update Post Date Type:
ESTIMATED